{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:53:25Z","timestamp":1790009605291,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.autrev.2024.103696","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T23:06:34Z","timestamp":1731884794000},"page":"103696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions"],"prefix":"10.1016","volume":"24","author":[{"given":"Heng","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2024.103696_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41584-024-01110-y","article-title":"Rethinking antiphospholipid syndrome to guide future management and research","volume":"20","author":"Knight","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103696_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2024.103696_bb0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2018.01.027","article-title":"Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: are they different entities?","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2024.103696_bb0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/0961203316637431","article-title":"The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus","volume":"25","author":"Taraborelli","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103696_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2019.00199","article-title":"Editorial: systemic lupus erythematosus and antiphospholipid syndrome","volume":"10","author":"Meroni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103696_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/JS9.0000000000002095","article-title":"Mapping the evolution of 3D printing in cardio-thoracic diseases: a global bibliometric analysis","author":"Tian","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.autrev.2024.103696_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jrsm.1729","article-title":"Beyond Google scholar, Scopus, and web of science: an evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices","author":"Gusenbauer","year":"2024","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.autrev.2024.103696_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.autrev.2024.103696_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"SI","key":"10.1016\/j.autrev.2024.103696_bb0050","doi-asserted-by":"crossref","first-page":"SI72","DOI":"10.1093\/rheumatology\/kead618","article-title":"The impact of antiphospholipid antibodies\/antiphospholipid syndrome on systemic lupus erythematosus","volume":"63","author":"Venturelli","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2024.103696_bb0055","doi-asserted-by":"crossref","first-page":"B41","DOI":"10.1016\/j.ajog.2022.09.001","article-title":"Society for maternal-fetal medicine consult series #64: systemic lupus erythematosus in pregnancy","volume":"228","author":"Silver","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103696_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100724","article-title":"Approach to pregnancy in patients with lupus nephritis","volume":"5","author":"Tan","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.autrev.2024.103696_bb0065","series-title":"19 Management of Pregnancy in SLE and APSLupus Science & Medicine","first-page":"9","author":"Buyon","year":"2022"},{"key":"10.1016\/j.autrev.2024.103696_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.05.007","article-title":"The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review","volume":"92","author":"Cervera","year":"2018","journal-title":"J Autoimmun"},{"issue":"20","key":"10.1016\/j.autrev.2024.103696_bb0075","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/bloodadvances.2021005205","article-title":"A systematic review of the association between anti-\u03b2-2 glycoprotein I antibodies and APS manifestations","volume":"5","author":"Jiang","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2024.103696_bb0080","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.autrev.2024.103696_bb0085","article-title":"Ischemic stroke revealing Libman-sacks endocarditis as the initial manifestation of lupus erythematosus with secondary antiphospholipid syndrome: a case report","volume":"16","author":"El Koubayati","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.autrev.2024.103696_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7274","article-title":"A novel overlap syndrome: rheumatoid arthritis, Sjogren\u2019s syndrome, antiphospholipid syndrome, and dermatomyositis","volume":"11","author":"Mohammed","year":"2023","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.autrev.2024.103696_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10067-017-3549-1","article-title":"Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with euro-phospholipid cohort","volume":"36","author":"Shi","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103696_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-257086","article-title":"Chorea as an initial and solitary manifestation of systemic lupus erythematosus with antiphospholipid syndrome in an elderly man","volume":"17","author":"Javed","year":"2024","journal-title":"BMJ Case Rep"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:06:03Z","timestamp":1734480363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1568997224001873"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103696","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103696"}}